Verdeca-BIOX Transactions - Additional Information (Detail) - USD ($)		1 Months Ended	3 Months Ended	12 Months Ended
	Nov. 12, 2020	Jun. 30, 2021	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Variable Interest Entity [Line Items]
Fixed consideration allocated to sale of membership interest				$ 569,000
Gain on sale of membership interests in Verdeca				1,138,000	0
Inventory contributed				2,571,000	4,433,000
Revenues				9,956,000	6,780,000
Gross proceeds on sale		$ 22,200,000
Proceeds from sale of Verdeca in accounts receivable and other receivables				569,000	0
Remaining accounts receivable and other receivables				1,287,000	1,370,000
License
Variable Interest Entity [Line Items]
Revenues				879,000	$ 17,000
Bioceres Crop Solutions [Member] | License
Variable Interest Entity [Line Items]
Revenues			$ 862,000
Verdeca LLC [Member]
Variable Interest Entity [Line Items]
Gain on sale of membership interests in Verdeca			$ 1,100,000
Verdeca LLC [Member] | Bioceres Crop Solutions [Member]
Variable Interest Entity [Line Items]
Milestone Payments Received				1,000,000.0
Verdeca LLC [Member] | Bioceres Crop Solutions [Member] | Accounts Receivables and Other Receivables [Member]
Variable Interest Entity [Line Items]
Milestone payment receivable from sale of interest in joint venture				$ 1,000,000.0
Verdeca LLC [Member] | Bioceres Crop Solutions [Member] | Master Transaction Agreement [Member]
Variable Interest Entity [Line Items]
Cash receivable from sale of interest in joint venture	$ 5,000,000
Shares of common stock receivable from sale of interest in joint venture	1,875,000
Additional cash receivable for transaction expenses and fees	$ 1,000,000
Milestone payment receivable from sale of interest in joint venture	$ 2,000,000
Sale of interest in joint venture, description of transaction				BIOX also paid the Company an additional $1,000,000 for transaction expenses and fees and is obligated to pay $2,000,000 in four equal quarterly payments with the first payment commencing within thirty days of either BIOX reaching commercial plantings of at least 200,000 hectares of HB4 soybeans or China approving the HB4 soybean trait for “food and feed”.
Percentage of royalty payments on net revenues	6.00%
Percentage of royalty payments on net revenues received from sales of licensed wheat products	25.00%
Sale of interest in joint venture, fixed consideration agreed amount	$ 16,968,750
Fixed consideration allocated to sale of membership interest	10,288,000
Corporate securities received allocated to sale of member ship interest	6,650,000
Gain on sale of membership interests in Verdeca						$ 8,814,000
Inventory contributed						1,474,000
Verdeca LLC [Member] | Bioceres Crop Solutions [Member] | Master Transaction Agreement [Member] | License
Variable Interest Entity [Line Items]
Revenues						6,680,000
Corporate securities						$ 4,318,000
Verdeca LLC [Member] | Bioceres Crop Solutions [Member] | Master Transaction Agreement [Member] | Maximum [Member]
Variable Interest Entity [Line Items]
Technology royalty revenue receivable on trait fees, from sale of interest in joint venture	$ 10,000,000